Abstract
The free living nematode worm Caenorhabditis elegans (C. elegans) has been extensively studied by biological, agricultural, and medical scientists for over 40 years. The animal has several characteristics that make it useful as a model organism. For example, the nematodes are transparent, which allows study of embryonic development and gene expression in living animals under the microscope. They also have a very short life cycle of about 3 days and a relatively short lifespan of about 3 weeks, which allow genetic dissection of the mechanisms that affect aging and ultimately determine lifespan. In addition, the mechanism of gene silencing by RNA interference has been discovered in C. elegans and has been developed into a potent reverse genetic tool.
Because of the strong conservation of molecular genetic pathways between C. elegans and mammals, it represents a powerful addition to the small animal model repertoire. Genetic mechanisms in human disease, such as Alzheimer’s disease, have been elucidated in C. elegans, indicating its potential as a model for human dementia. Here, we will discuss the existing models, and what they have revealed about the genetic pathways and pathogenesis of different forms of dementia. We will also describe how to set up forward and reverse genetic screens in C. elegans, which can be used to identify additional genes and processes involved in dementia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Brenner S (v1974) The genetics of Caenorhabditis elegans. Genetics 77(1):71–94
Byerly L, Cassada RC, Russell RL (1976) The life cycle of the nematode Caenorhabditis elegans. I. Wild-type growth and reproduction. Dev Biol 51(1):23–33
Lewis JA, Fleming JT (1995) Basic culture methods. Methods Cell Biol 48:3–29
Sulston JE, Schierenberg E, White JG, Thomson JN (1983) The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 100(1):64–119
Wood WB (1988) Determination of pattern and fate in early embryos of Caenorhabditis elegans. Dev Biol (N Y 1985) 5:57–78
White JG, Southgate E, Thomson JN, Brenner S (1986)The structure of the nervous systemn of the nematode Caenorhabditis elegans. Phil Trans Royal Soc London Series B, Biol Sci 314:1–340
Sulston JE, Horvitz HR (1977) Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56(1): 110–156
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669):806–811
Tabara H, Grishok A, Mello CC (1998) RNAi in C. elegans: Soaking in the genome sequence. Science 282(5388):430–431
Timmons L, Fire A (1998) Specific interference by ingested dsRNA. Nature 395(6705):854
Timmons L, Court DL, Fire A (2001) Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263(1–2):103–112
Kamath RS, Ahringer J (2003) Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30(4):313–321
Kamath RS, Fraser AG, Dong Y, et al. (2003) Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421(6920):231–237
Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101–112
Levitan D, Greenwald I (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer’s disease gene. Nature 377(6547):351–354
Li X, Greenwald I (1997) HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc Natl Acad Sci U S A 94(22): 12204–12209
Levitan D, Doyle TG, Brousseau D, et al. (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci U S A 93(25): 14940–14944
Lakowski B, Eimer S, Gobel C, Bottcher A, Wagler B, Baumeister R (2003) Two suppressors of sel-12 encode C2H2 zinc-finger proteins that regulate presenilin transcription in Caenorhabditis elegans. Development 130(10): 2117–2128
Jarriault S, Greenwald I (2002) Suppressors of the egg-laying defective phenotype of sel-12 presenilin mutants implicate the CoREST corepressor complex in LIN-12/Notch signaling in C. elegans. Genes Dev 16(20):2713–2728
Hornsten A, Lieberthal J, Fadia S, et al. (2007) APL-1, a Caenorhabditis elegans protein related to the human beta-amyloid precursor protein, is essential for viability. Proc Natl Acad Sci U S A 104(6):1971–1976
Sakaguchi-Nakashima A, Meir JY, Jin Y, Matsumoto K, Hisamoto N (2007) LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins. Curr Biol 17(7):592–598
Schmidt E, Seifert M, Baumeister R (2007) Caenorhabditis elegans as a model system for Parkinson’s disease. Neurodegener Dis 4(2–3):199–217
Springer W, Hoppe T, Schmidt E, Baumeister R (2005) A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress. Hum Mol Genet 14(22):3407–3423
Wu Y, Wu Z, Butko P, et al. (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26(50):13102–13113
Link CD (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A 92(20):9368–9372
Holzenberger M, Dupont J, Ducos B, et al. (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421(6919):182–187
Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity. Science 313(5793):1604–1610
Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164–173
Cabin DE, Shimazu K, Murphy D, et al. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22(20):8797–8807
Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123(3): 383–396
Larsen KE, Schmitz Y, Troyer MD, et al. (2006) Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci 26(46):11915–11922
Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20(9):3214–3220
Morley JF, Brignull HR, Weyers JJ, Morimoto RI (2002) The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A 99(16):10417–10422
Satyal SH, Schmidt E, Kitagawa K, et al. (2000) Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci U S A 97(11):5750–5755
van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH, Nollen EA (2008) C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet 4(3):e1000027
Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD (2003) Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A 100(17):9980–9985
Kraemer BC, Burgess JK, Chen JH, Thomas JH, Schellenberg GD (2006) Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Hum Mol Genet 15(9):1483–1496
Praitis V, Casey E, Collar D, Austin J (2001) Creation of low-copy integrated transgenic lines in Caenorhabditis elegans. Genetics 157(3):1217–1226
Wilm T, Demel P, Koop HU, Schnabel H, Schnabel R (1999) Ballistic transformation of Caenorhabditis elegans. Gene 229(1–2): 31–35
Jorgensen EM, Mango SE (2002) The art and design of genetic screens: Caenorhabditis elegans. Nat Rev Genet 3(5):356–369
Koch R, van Luenen HG, van der HM, Thijssen KL, Plasterk RH (2000) Single nucleotide polymorphisms in wild isolates of Caenorhabditis elegans. Genome Res 10(11):1690–1696
Jansen G, Hazendonk E, Thijssen KL, Plasterk RH (1997) Reverse genetics by chemical mutagenesis in Caenorhabditis elegans. Nat Genet 17(1):119–121
Zwaal RR, Broeks A, van MJ, Groenen JT, Plasterk RH (1993) Target-selected gene inactivation in Caenorhabditis elegans by using a frozen transposon insertion mutant bank. Proc Natl Acad Sci U S A 90(16): 7431–7435
Carroll D, Beumer KJ, Morton JJ, Bozas A, Trautman JK (2008) Gene targeting in Drosophila and Caenorhabditis elegans with zinc-finger nucleases. Methods Mol Biol 435:63–77
Morton J, Davis MW, Jorgensen EM, Carroll D (2006) Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells. Proc Natl Acad Sci U S A 103(44):16370–16375
Ashrafi K, Chang FY, Watts JL, et al. (2003) Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421(6920):268–272
Rual JF, Ceron J, Koreth J, et al. (2004) Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res 14(10B):2162–2168
Boutros M, Ahringer J (2008) The art and design of genetic screens: RNA interference. Nat Rev Genet 9(7):554–566
Nollen EA, Garcia SM, van HG, et al. (2004) Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A 101(17):6403–6408
van Haaften G., Vastenhouw NL, Nollen EA, Plasterk RH, Tijsterman M (2004) Gene interactions in the DNA damage-response pathway identified by genome-wide RNA-interference analysis of synthetic lethality. Proc Natl Acad Sci U S A 101(35):12992–12996
Eimer S, Lakowski B, Donhauser R, Baumeister R (2002) Loss of spr-5 bypasses the requirement for the C.elegans presenilin sel-12 by derepressing hop-1. EMBO J 21(21):5787–5796
Wen C, Levitan D, Li X, Greenwald I (2000) spr-2, a suppressor of the egg-laying defect caused by loss of sel-12 presenilin in Caenorhabditis elegans, is a member of the SET protein subfamily. Proc Natl Acad Sci U S A 97(26):14524–14529
van Haaften G, Romeijn R, Pothof J, et al. (2006) Identification of conserved pathways of DNA-damage response and radiation protection by genome-wide RNAi. Curr Biol 16(13):1344–1350
Acknowledgments
The authors thank J. Senior for editing the manuscript and ZonMw (NWO), Research Institute for Diseases in the Elderly (RIDE), for the funding.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Van Ham, T.J., Nollen, E.A.A. (2011). Caenorhabditis elegans as a Model Organism for Dementia. In: De Deyn, P., Van Dam, D. (eds) Animal Models of Dementia. Neuromethods, vol 48. Humana Press. https://doi.org/10.1007/978-1-60761-898-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-60761-898-0_13
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-897-3
Online ISBN: 978-1-60761-898-0
eBook Packages: Springer Protocols